Background Albumin-to-alkaline phosphatase ratio (AAPR), a novel and economic serum
biomarker, is associated with survival in patients with cancer. This study aimed to evaluate …

Background. Recently, it has been reported that the pretreatment albumin‐to‐alkaline
phosphatase ratio (AAPR) is related to the prognosis of various cancers. The purpose of this …

Simple Summary Since the albumin-to-alkaline phosphatase ratio (AAPR) has shown
promising prognostic prediction in cancer patients, the prognostic value of the AAPR was …

Background The impact of albumin-to-alkaline phosphatase ratio (AAPR) on prognosis in
cancer patients remains uncertain, despite having multiple relevant studies in publication …

Background The albumin-to-alkaline phosphatase ratio (AAPR) is an innovative prognostic
index for various cancer patients, the clinical significance of the AAPR in patients with GC is …

Purpose To investigate the prognostic value of combined serum carcinoembryonic antigen
(CEA) levels and fibrinogen/albumin ratio (FAR) in patients with resectable gastric cancer …

OBJECTIVE: Inflammation forms the basis of cancer development and progression. It causes
changes in complete blood count parameters, such as neutrophil counts. Low albumin …

Objective Serum albumin-to-alkaline phosphatase ratio (AAPR) has been proven to be a
prognostic indicator of many malignant tumors. However, whether it can predict the …

The association between pretreatment albumin-to-alkaline phosphatase ratio (AAPR) and
clinicopathological parameters and prognosis in lung cancer is unclear. The study aimed to …

Purpose It has been demonstrated that, for various types of cancer, the pretreatment
albumin/alkaline phosphatase ratio (AAPR) was a prognostic factor. Therefore, in order to …